Cardlytics, Inc. (CDLX) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-05-12

Key Insights

Chief Legal and Privacy Officer Nick Lynton is departing, with transition lasting until July 3, 2026 or upon successor appointment, indicating potential leadership instability during the transition period.
Total separation costs of approximately $450,320 ($380,000 lump sum + $70,320.21 additional payment in Q1 2027) plus 12 months of COBRA reimbursement represent a notable near-term expense impact.
The company has implemented a structured transition plan with Mr. Lynton remaining in an advisory role post-successor appointment, which should mitigate operational and knowledge transfer risks during the leadership change.
The replacement of the prior Separation Pay Agreement with a new Transition Agreement suggests the company is managing executive departures more strategically, though the timing and circumstances of this resignation remain undisclosed.

Want the newest filings?

This analysis covers the filing from 2026-05-12. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-05-07

Cardlytics released Q1 2026 earnings results on May 7, 2026, indicating the company is maintaining regular financial reporting cadence and investor communication practices.
The 8-K filing is a routine earnings announcement with no indication of material events, acquisitions, leadership changes, or significant corporate developments beyond standard quarterly results disclosure.
The filing was signed by David Evans, CFO, confirming proper financial officer authorization and that results were officially announced via press release (Exhibit 99.1) rather than as filed financial statements.

Filed: 2026-03-24

Cardlytics, Inc. has completed the sale of its Bridg platform to PAR Technology Corporation for consideration of 1,810,222 shares of PAR's common stock.
The unaudited pro forma condensed consolidated financial statements provide insights into the financial impact of the Bridg platform divestiture on Cardlytics' financials.
The transaction allows Cardlytics to focus on its core business and could potentially improve its financial performance going forward.

Filed: 2026-03-04

Cardlytics, Inc. reported its Q4 2025 and full-year 2025 financial results, highlighting the company's recent corporate developments.
The company provided information regarding an upcoming conference call to discuss the financial results and recent highlights.
Investors will be interested in analyzing the company's revenue trends, margin changes, and any guidance or risk factors presented in the upcoming earnings call.

Filed: 2026-01-26

Cardlytics, Inc. (CDLX) has entered into an asset purchase agreement to sell its Bridg platform to PAR Technology Corporation (PAR) for up to $30 million in PAR common stock.
The sale of the Bridg platform is a strategic move for Cardlytics, allowing it to focus on its core business and optimize its operations.
The transaction is subject to customary closing conditions and is expected to be completed by March 24, 2026.

Other reports for Cardlytics, Inc.

Quarterly Report Insider Trading Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.